CHMP4B and hepatocellular carcinoma: The silence of both CHMP4B and Vps4A decrease the level of exosomal β-catenin, thus dampening β-catenin signing so as to prevent epithelial–mesenchymal transition (EMT) in hepatocellular carcinoma (HCC) [37].